Skip to main content
. 2023 Dec 19;14:1272754. doi: 10.3389/fmicb.2023.1272754

FIGURE 1.

FIGURE 1

Overview of main regulatory categories of probiotics (PF, PDS, LBPs). Of note, the use of PF and PDS is not excluded in a diseased individual to support health for similar purposes as in healthy individuals, however here we emphasize the target population from a regulatory perspective. Elaborated by the authors from various sources.